About Roche
About Roche
Sustainability
Governance
Personalised Healthcare
Solutions
Solutions
Focus areas
Pharma solutions
Diagnostic solutions
Diabetes care
Innovation
Innovation
Clinical trials
Partnering
Stories
Media
Careers
Tecentriq® (atezolizumab)
Pharmaceutical Product Information
Availability of Tecentriq® (atezolizumab)
1875 mg/15 mL solution for subcutaneous injection
Intravenous (IV) solution for infusion